The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in sales , its intellectual property lapse created a deluge of knock-off medications, significantly diminishing its position . While certain pharmaceutical companies may seek to capitalize on male sexual